Literature DB >> 22728492

Anti-centromere antibody-positive subjects presenting with hypertensive emergency and renal dysfunction in the absence of skin manifestations: a variant of systemic sclerosis or a novel entity?

Shintaro Mandai1, Yohei Arai, Suguru Hirasawa, Toshiyuki Hirai, Shota Aki, Naoto Inaba, Makoto Aoyagi, Hiroyuki Tanaka, Teiichi Tamura, Sei Sasaki.   

Abstract

Two patients with anti-centromere antibody (ACA), hypertensive emergency, and acute renal failure, mimicking scleroderma renal crisis, without Raynaud's phenomenon and typical skin manifestations of systemic sclerosis (SSc), are reported. A review of 26 ACA-positive patients between March 2003 and March 2011 in Yokosuka Kyosai Hospital identified four additional patients with similar manifestations. All patients were Japanese women between 41 and 84 years of age at presentation. Human leukocyte antigen (HLA) genotyping tests revealed the absence of the HLA-DQB1*0501 and DRB1*0101 alleles, which are associated with disease susceptibility to ACA-positive SSc among Japanese. These subjects' manifestations may represent a novel entity.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22728492     DOI: 10.2169/internalmedicine.51.6924

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  2 in total

1.  Anti-centromere antibody is an independent risk factor for chronic kidney disease in patients with primary biliary cirrhosis.

Authors:  Shintaro Mandai; Eiichiro Kanda; Yohei Arai; Suguru Hirasawa; Toshiyuki Hirai; Shota Aki; Naoto Inaba; Makoto Aoyagi; Hiroyuki Tanaka; Takaaki Ikeda; Teiichi Tamura; Sei Sasaki
Journal:  Clin Exp Nephrol       Date:  2012-12-26       Impact factor: 2.801

2.  Clinical and autoimmune profile of scleroderma patients from Western India.

Authors:  Vandana Pradhan; Anjali Rajadhyaksha; Milind Nadkar; Pallavi Pandit; Prathamesh Surve; Maxime Lecerf; Jagadeesh Bayry; Srinivas Kaveri; Kanjaksha Ghosh
Journal:  Int J Rheumatol       Date:  2014-10-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.